NCT Number,Title,Status,Study Results,Interventions,Gender,Age,URL
NCT01512251,BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma,Completed,Has Results,Drug: BKM120 Combined with Vemurafenib (PLX4032),male,"18 Years and 76 Years (Adult, Older Adult)",https://ClinicalTrials.gov/show/NCT01512251